Niels Svenstrup
Corporate Officer/Principal bij PEPGEN INC.
Vermogen: 147 000 $ op 31-03-2024
Profiel
Niels Svenstrup is currently the SVP-Chemistry, Manufacturing & Control at PepGen Inc. Prior to this, he was the Senior Vice President-Development at Cydan II, Inc. from 2017 to 2021.
He was also the Director-CMC at Ascendis Pharma A from 2015 to 2017 and the Head-Medicinal Chemistry Department at H.
Lundbeck A from 2008 to 2015.
Dr. Svenstrup holds a graduate and doctorate degree from the University of Southern Denmark.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PEPGEN INC.
0.03% | 01-03-2024 | 10 000 ( 0.03% ) | 147 000 $ | 31-03-2024 |
Actieve functies van Niels Svenstrup
| Bedrijven | Functie | Begin |
|---|---|---|
| PEPGEN INC. | Corporate Officer/Principal | 01-04-2021 |
Eerdere bekende functies van Niels Svenstrup
| Bedrijven | Functie | Einde |
|---|---|---|
Cydan II, Inc.
 Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Cydan II, Inc. develops and commercializes drugs for orphan and diseases. The firm evaluates products for treating rare diseases with high unmet medical need to start multiple companies to develop such therapies. The company was founded by Cristina Csimma, James G. McArthur, Deborah S. Geraghty and Christoph M. Adams in 2013 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-04-2021 |
| ASCENDIS PHARMA A/S | Corporate Officer/Principal | 01-07-2017 |
| H. LUNDBECK A/S | Corporate Officer/Principal | 01-11-2015 |
Opleiding van Niels Svenstrup
| University of Southern Denmark | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| H. LUNDBECK A/S | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| PEPGEN INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Cydan II, Inc.
Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Cydan II, Inc. develops and commercializes drugs for orphan and diseases. The firm evaluates products for treating rare diseases with high unmet medical need to start multiple companies to develop such therapies. The company was founded by Cristina Csimma, James G. McArthur, Deborah S. Geraghty and Christoph M. Adams in 2013 and is headquartered in Cambridge, MA. | Health Technology |
